Skip to content

CBD Topicals Practitioner Impact Report

Real-World Findings from Repeated Professional CBD Topical Use in Massage Therapy

Carpe Diem CBD Topicals were evaluated during 24 weeks of active massage therapy practice, resulting in 508 practitioner exposure reports collected from 71 professional massage therapists.

24 Weeks | 71 Therapists | 508 Exposure Reports | 97% Practitioner-Reported Benefit

Shop SPA REVIVE & SPA SOOTHE
 
Download the Full Practitioner Impact Report

Why Therapist Wellness Matters

Massage therapists rely on their hands, wrists, and forearms throughout every session. Over time, repetitive movements, sustained pressure, and high client volume can create cumulative physical demands that affect comfort, recovery, and long-term career sustainability. As CBD topical products become increasingly common in professional massage settings, understanding their impact during repeated use, including therapist safety and practitioner-reported outcomes is increasingly important.

This practitioner-impact analysis was conducted to evaluate therapist experiences with Carpe Diem CBD topicals during real-world massage therapy sessions.


Massage Therapist Impact Analysis Highlights

Real-World Professional Use Evaluation

Study Overview:

  • Repeated daily application during professional massage sessions
  • Assessment of practitioner-reported benefit and safety outcomes
  • Evaluation of repeated-use safety observations
  • Focus on upper-extremity demands associated with professional bodywork

Areas Evaluated:

  • Hands
  • Wrists
  • Forearms
  • Workload intensity
  • Repeated dermal exposure

Key Findings

97% Practitioner-Reported Benefit
Therapists reported positive experiences during repeated professional use.

Upper-Extremity Support
Therapist-reported discomfort decreased consistently across hands, wrists, and forearms.

Strong Safety Profile
0.0% cognitive disruption reported. Adverse events remained minimal during repeated professional use, with no correlation observed between session volume and adverse events.

Greatest Improvement Observed
Reported among therapists performing higher-volume, shorter-duration sessions.

Formulation Comparison
Spa Revive demonstrated slightly higher practitioner-reported benefit and slightly lower adverse-event rates than Spa Soothe during the evaluation period.

 

 

Upper Extremity Support Findings

Practitioner-reported outcomes demonstrated consistent improvement across the upper-extremity areas most affected by repetitive professional bodywork.

Experience the Formulations Evaluated in Professional Practice

The practitioner-impact analysis included repeated professional use of both Spa Revive and Spa Soothe formulations.

Shop SPA REVIVE | Shop SPA SOOTHE


Therapist Testimonials

The following testimonials reflect practitioner experiences using Carpe Diem CBD Topicals during professional massage therapy sessions.

“As someone who treats clients all day, taking care of my own hands is essential. Since using Carpe Diem CBD creams, I’ve noticed less discomfort in my hands and wrists after consecutive treatment sessions. It’s become an important part of supporting the physical demands of my work and helping me continue doing what I love.”

— Elena, Licensed Massage Therapist

“Using Carpe Diem CBD creams has become part of my routine between clients. My hands and forearms feel more comfortable throughout the day, which has made a noticeable difference during busy weeks.”
— Lydia, Licensed Massage Therapist

“Recovery between clients is just as important as caring for my clients. Applying Carpe Diem CBD creams throughout the day has become an important part of supporting my own well-being.”
— Owen, Licensed Massage Therapist


CBD Formulations Used Throughout the Analysis:

Both Spa Revive and Spa Soothe were evaluated throughout the practitioner-impact analysis during repeated professional massage therapy use.

             

Spa Revive

Full Spectrum CBD

<0.3% THC

Uplifting Scent Profile

 

Spa Soothe

Isolate CBD

THC Free

Unscented


Disclaimer:

Data analyzed using the Applied Practice Results Operating System (APROS) under RFOS ProofEngine. APROS Verified Statistics are produced using proprietary methodology owned exclusively by Shrinking Complexity LLC (“SC”) and licensed to ResultFlowOS Inc. (“RFOS”). The methodology, compilation architecture, evidence classification framework, outcome governance system, and all associated processes constitute proprietary trade secrets of SC and are protected under applicable trade secret laws including the Defend Trade Secrets Act (18 U.S.C. § 1836). Patent pending, covering the governed compilation and certification methodology iThese statistics are provided for informational and research purposes only. They do not constitute medical advice, clinical recommendations, regulatory submissions, or product performance certifications. Results reflect outcomes within the specific dataset described and may not be generalizable beyond that dataset. Use of these statistics in any marketing, advertising, or public-facing claim requires a valid sublicense agreement with RFOS. Unauthorized reproduction, distribution, reverse engineering, or replication of the underlying methodology is strictly prohibited and may result in legal action.

© 2026 Shrinking Complexity LLC. All rights reserved. RFOS, ResultFlow OS, and Shrinking Complexity are trademarks of Shrinking Complexity LLC. Powered by Applied Practice Results Operating System — www.apros.io